Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):2006–2008. doi: 10.1128/aac.41.9.2006

Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin.

J R Forney 1, S Yang 1, M C Healey 1
PMCID: PMC164053  PMID: 9303402

Abstract

The combined effect of the serine protease inhibitor alpha-1-antitrypsin (AAT) and the aminoglycoside paromomycin on Cryptosporidium parvum infection in vitro was investigated. AAT and paromomycin were mixed with C. parvum oocysts as either single or combined treatments and used to inoculate epithelial cell cultures. Single- and combined-treatment groups had significantly lower (P < 0.01) parasite numbers than untreated controls. The mean fractional inhibitory concentration indices suggested significant synergistic activity.

Full Text

The Full Text of this article is available as a PDF (220.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen L. B., Vanderslice L. K., Fingal C. M., McCright F. H., Harris E. F., Cook P. D. Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine. Antiviral Res. 1982 Sep;2(4):203–216. doi: 10.1016/0166-3542(82)90043-2. [DOI] [PubMed] [Google Scholar]
  2. Arrowood M. J., Sterling C. R. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol. 1987 Apr;73(2):314–319. [PubMed] [Google Scholar]
  3. Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
  4. Bissuel F., Cotte L., Rabodonirina M., Rougier P., Piens M. A., Trepo C. Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis. 1994 Mar;18(3):447–449. doi: 10.1093/clinids/18.3.447. [DOI] [PubMed] [Google Scholar]
  5. Clezy K., Gold J., Blaze J., Jones P. Paromomycin for the treatment of cryptosporidial diarrhoea in AIDS patients. AIDS. 1991 Sep;5(9):1146–1147. [PubMed] [Google Scholar]
  6. Edlind T. D. Susceptibility of Giardia lamblia to aminoglycoside protein synthesis inhibitors: correlation with rRNA structure. Antimicrob Agents Chemother. 1989 Apr;33(4):484–488. doi: 10.1128/aac.33.4.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fayer R., Ellis W. Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. J Parasitol. 1993 Aug;79(4):553–558. [PubMed] [Google Scholar]
  8. Fayer R., Ellis W. Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. J Parasitol. 1993 Oct;79(5):771–774. [PubMed] [Google Scholar]
  9. Fichtenbaum C. J., Ritchie D. J., Powderly W. G. Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clin Infect Dis. 1993 Feb;16(2):298–300. doi: 10.1093/clind/16.2.298. [DOI] [PubMed] [Google Scholar]
  10. Flanigan T. P., Ramratnam B., Graeber C., Hellinger J., Smith D., Wheeler D., Hawley P., Heath-Chiozzi M., Ward D. J., Brummitt C. Prospective trial of paromomycin for cryptosporidiosis in AIDS. Am J Med. 1996 Mar;100(3):370–372. doi: 10.1016/S0002-9343(97)89499-5. [DOI] [PubMed] [Google Scholar]
  11. Forney J. R., Yang S., Du C., Healey M. C. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol. 1996 Aug;82(4):638–640. [PubMed] [Google Scholar]
  12. Forney J. R., Yang S., Healey M. C. Protease activity associated with excystation of Cryptosporidium parvum oocysts. J Parasitol. 1996 Dec;82(6):889–892. [PubMed] [Google Scholar]
  13. Hamour A. A., Bonnington A., Hawthorne B., Wilkins E. G. Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. AIDS. 1993 Nov;7(11):1449–1451. doi: 10.1097/00002030-199311000-00007. [DOI] [PubMed] [Google Scholar]
  14. Healey M. C., Yang S., Rasmussen K. R., Jackson M. K., Du C. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J Parasitol. 1995 Feb;81(1):114–116. [PubMed] [Google Scholar]
  15. Mac Kenzie W. R., Hoxie N. J., Proctor M. E., Gradus M. S., Blair K. A., Peterson D. E., Kazmierczak J. J., Addiss D. G., Fox K. R., Rose J. B. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med. 1994 Jul 21;331(3):161–167. doi: 10.1056/NEJM199407213310304. [DOI] [PubMed] [Google Scholar]
  16. Marshall R. J., Flanigan T. P. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J Infect Dis. 1992 Apr;165(4):772–774. doi: 10.1093/infdis/165.4.772. [DOI] [PubMed] [Google Scholar]
  17. Nesterenko M. V., Tilley M., Upton S. J. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios. 1995;83(335):77–88. [PubMed] [Google Scholar]
  18. O'Donoghue P. J. Cryptosporidium and cryptosporidiosis in man and animals. Int J Parasitol. 1995 Feb;25(2):139–195. doi: 10.1016/0020-7519(94)e0059-v. [DOI] [PubMed] [Google Scholar]
  19. Okhuysen P. C., Chappell C. L., Kettner C., Sterling C. R. Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation. Antimicrob Agents Chemother. 1996 Dec;40(12):2781–2784. doi: 10.1128/aac.40.12.2781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Okhuysen P. C., DuPont H. L., Sterling C. R., Chappell C. L. Arginine aminopeptidase, an integral membrane protein of the Cryptosporidium parvum sporozoite. Infect Immun. 1994 Oct;62(10):4667–4670. doi: 10.1128/iai.62.10.4667-4670.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rehg J. E. A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. J Infect Dis. 1994 Oct;170(4):934–938. doi: 10.1093/infdis/170.4.934. [DOI] [PubMed] [Google Scholar]
  22. Tzipori S., Rand W., Griffiths J., Widmer G., Crabb J. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin Diagn Lab Immunol. 1994 Jul;1(4):450–463. doi: 10.1128/cdli.1.4.450-463.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Verdon R., Polianski J., Gaudebout C., Marche C., Garry L., Pocidalo J. J. Evaluation of curative anticryptosporidial activity of paromomycin in a dexamethasone-treated rat model. Antimicrob Agents Chemother. 1994 Jul;38(7):1681–1682. doi: 10.1128/aac.38.7.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yang S., Healey M. C., Du C., Zhang J. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect Immun. 1996 Jan;64(1):349–354. doi: 10.1128/iai.64.1.349-354.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES